1,264
Views
3
CrossRef citations to date
0
Altmetric
Laboratory Study

Potential biomarkers associated with diabetic glomerulopathy through proteomics

, , , &
Pages 1308-1315 | Received 11 Feb 2015, Accepted 24 Jul 2015, Published online: 12 Sep 2015

References

  • Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton). 2010;15(Suppl 2):3–9
  • Berkman J, Rifkin H. Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson): Report of a case. Metabolism. 1973;22(5):715–722
  • Najafian B, Alpers CE, Fogo AB. Pathology of human diabetic nephropathy. Contrib Nephrol. 2011;170:36–47
  • Armstrong JD, Pocklington AJ, Cumiskey MA, Grant SG. Reconstructing protein complex: From proteomics to systems biology. Proteomics. 2006;6:4724–4731
  • Sze SK, De Kleijn DP, Lai RC, et al. Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol Cell Proteomics. 2007;6:1680–1689
  • Chambers G, Lawrie L, Cash P, Murray GI. Proteomics – a new approach to the study of disease. J Pathol. 2000;192:280–288
  • Tyther R, Ahmeda A, Johns E, Sheehan D. Proteomic identification of tyrosine nitration targets in kidney of spontaneously hypertensive rats. Proteomics. 2007;7(24):4555–4564
  • Hoorn EJ, Hoffert JD, Knepper MA. Combined proteomics and pathways analysis of collecting duct reveals a protein regulatory network activated in vasopressin escape. J Am Soc Nephrol. 2005;16(10):2852–2863
  • Traum AZ, Schachter AD. Proteomic analysis in pediatric renal disease. Semin Nephrol. 2007;27(6):652–657
  • Thongboonkerd V. Proteomics in nephrology: Current status and future directions. Am J Nephrol. 2004;24(3):360–378
  • Viney RL, Morrison AA, van den Heuvel LP, et al. A proteomic investigation of glomerular podocytes from a Denys-Drash syndrome patient with a mutation in the Wilms tumour suppressor gene WT1. Proteomics. 2007;7(5):804–815
  • Blutke A. Opening a treasure chest: Glomerular proteome analyses of formalin-fixed paraffin-embedded kidney tissue in the investigation of diabetic nephropathy. Nephrol Dial Transplant. 2012;27(5):1695–1698
  • Lin CL, Wang JY, Huang YT, Kuo YH, Surendran K, Wang FS. Wnt/beta-catenin signaling modulates survival of high glucose-stressed mesangial cells. J Am Soc Nephrol. 2006;17(10):2812–2820
  • Takemoto M, Asker N, Gerhardt H, et al. A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol. 2002;161:799–805
  • Pastorelli R, Carpi D, Airoldi L, et al. Proteome analysis for the identification of in vivo estrogen-regulated proteins in bone. Proteomics. 2005;5:4936–4945
  • Fan Y, Liu J, Wang S, et al. Functional proteome of bones in rats with osteoporosis following ovariectomy. Life Sci. 2005;76:2893–2901
  • Tan X, Cai D, Wu Y, et al. Comparative analysis of serum proteomes: Discovery of proteins associated with osteonecrosis of the femoral head. Translat Res. 2006;148:114–119
  • Pastorelli R, Carpi D, Airoldi L, et al. Proteome analysis for the identification of in vivo estrogen-regulation protein in bone. Proteomics. 2005;5:4936–4945
  • Alter ML, Kretschmer A, Von Websky K, et al. Early urinary and plasma biomarkers for experimental diabetic nephropathy. Clin Lab. 2012;58(7–8):659–671
  • Yang Y, Xiao L, Li J, Kanwar YS, Liu F, Sun L. Urine miRNAs: Potential biomarkers for monitoring progression of early stages of diabetic nephropathy. Med Hypotheses. 2013;81(2):274–278
  • Najafian B, Alpers CE, Fogo AB. Pathology of human diabetic nephropathy. Contrib Nephrol. 2011;170:36–47
  • Jessop CE, Chakravarthi S, Garbi N, Hämmerling GJ, Lovell S, Bulleid NJ. ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. EMBO J. 2007;26(1):28–40
  • Peaper DR, Wearsch PA, Cresswell P. Tapasin and ERp57 form a stable disulfide-linked dimer within the MHC class I peptide-loading complex. EMBO J. 2005;24(20):3613–3623
  • Khanal RC, Nemere I. The ERp57/GRp58/1,25D3-MARRS receptor: Multiple functional roles in diverse cell systems. Curr Med Chem. 2007;14(10):1087–1093
  • Wu J, Zhang R, Torreggiani M, et al. Induction of diabetes in aged C57B6 mice results in severe nephropathy: An association with oxidative stress, endoplasmic reticulum stress, and inflammation. Am J Pathol. 2010;176(5):2163–2176
  • Kirimca F, Sarioğlu S, Camsari T, Kavukçu S. Expression of CD44 and major histocompatibility complex class II antigens correlate with renal scarring in primary and systemic renal diseases. Scand J Urol Nephrol. 2001;35(6):509–514
  • Giwercman B, Meyer C, Lambert PA, Reinert C, Høiby N. High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment. Antimicrob Agents Chemother. 1992;36(1):71–76
  • Pushkin A, Carpenito G, Abuladze N, et al. Structural characterization, tissue distribution, and functional expression of murine aminoacylase III. Am J Physiol Cell Physiol. 2004;286(4):C848–C856
  • Chen YR, Chen TY, Zhang SL, et al. Identification of a novel protein binding to hepatitis C virus core protein. J Gastroenterol Hepatol. 2009;24(7):1300–1304
  • Wu HZ, Guo L, Mak YF, et al. Proteomics investigation on aristolochic acid nephropathy: A case study on rat kidney tissues. Anal Bioanal Chem. 2011;399(10):3431–3439
  • Pozdzik AA, Berton A, Schmeiser HH, et al. Aristolochic acid nephropathy revisited: A place for innate and adaptive immunity? Histopathology. 2010;56(4):449–463
  • Xie H, Tao Y, Lv J, Liu P, Liu C. Proteomic analysis of the effect of fuzheng huayu recipe on fibrotic liver in rats. Evid Based Complement Alternat Med. 2013;2013:972863
  • Sato S, Genda T, Hirano K, et al. Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: Association with serum alpha-fetoprotein and hepatocellular carcinoma. Liver Int. 2012;32(9):1382–1390
  • Dozmorov MG, Azzarello JT, Wren JD, et al. Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: Implications for prostate cancer progression. BMC Cancer. 2010;10:672
  • Rengo G, Cannavo A, Liccardo D, et al. Vascular endothelial growth factor blockade prevents the beneficial effects of β-blocker therapy on cardiac function, angiogenesis and remodeling in heart failure. Circ Heart Fail. 2013;6(6):1259–1267
  • Ni H, Chen J, Pan M, et al. FTY720 prevents progression of renal fibrosis by inhibiting renal microvasculature endothelial dysfunction in a rat model of chronic kidney disease. J Mol Histol. 2013;44(6):693–703
  • Rhee SG, Chae HZ, Kim K. Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med. 2005;38:11–17
  • Rhee SG. Cell signaling. H2O2, a necessary evil for cell signaling. Science. 2006;312:1882–1883
  • Neumann CA, Cao J, Manevich Y. Peroxiredoxin 1 and its role in cell signaling. Cell Cycle. 2009;8(24):4072–4078
  • Lin CL, Wang FS, Kuo YR, et al. Ras modulation of superoxide activates ERK-dependent fibronectin expression in diabetes-induced renal injuries. Kidney Int. 2006;69(9):1593–1600
  • Korrapati MC, Shaner BE, Neely BA, Alge JL, Arthur JM, Schnellmann RG. Diabetes-induced renal injury in rats is attenuated by suramin. J Pharmacol Exp Ther. 2012;343(1):34–43

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.